PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
April 26, 2012 | ISSUE NUMBER 248 VOL 8

Legal
Sales Reps v. Pharma: What the Overtime Case Could Mean for Pharma
The Supreme Court's Decision on whether sales reps should qualify for the 'outside sales exemption' could have far reaching implications for pharma, write Lisa A. Schreter and Kimberly J. Gost ...Read more

Companies
Dare to Compare: Genzyme Bets on MS
Riding positive data on a late-phase multiple sclerosis drug, Genzyme execs talked up the company’s MS franchise and willingness to go head-to-head against Rebif, EMD Serono and Pfizer’s blockbuster beta interferon ...Read More

Case Study: How a Biotech Saved $600,000 on a CRO Contract
Download a new case study to discover how a small biotech applied innovative eClinical software to:
* Save $600,000 on a single Phase II outsourcing contract
* Compress the contracting cycle-time from three months to two weeks
* Form a more constructive and collaborative working relationship with their CRO
Download Now

Regulatory
FDA Addresses Globalization
A new report details the strategies, programs, and other activities the Agency is using to address the rise of imported pharmaceutical products ...Read More

Global
Europe Responds to Troubled Medical Devices Sector
EU health ministers have stepped carefully around medical devices, but the recent scandal concerning breast implants has the European Parliament baying for action. As a result, no pharmaceutical executive should ignore what happens in the sector over the coming months, says Reflector
...Read more

Special Feature
Finding Success in Pharma as a Woman or Minority Professional
Go global. Broaden your industry exposure. Think beyond yourself. And create a strategic plan around the most important product: you. Timely advice from this year's HBA Woman of the Year, Carolyn Buck Luce
...Read more

// Quintiles appointed Tom Pike as its new Chief Executive. // Novartis promoted Brian McNamara from President Novartis OTC Americas to head of its entire over-the-counter division. // Dr Charlotte Kremer has moved from Pfizer to lead Astellas' new global medical affairs organization, based at it US headquarters in Illinois. // Tony Mauro, President of Mylan Pharmaceuticals, has been elected chair of the Generic Pharmaceutical Association (GPhA).
Improving Efficiency through Process Transformation
Live Webcast: Thursday, May 17, 2012 at 2:00PM EDT
Register Free at http://www.pharmexec.com/software.

May 7–8: Bio/Pharma Forum on Regulatory Policy
Washington, DC


June 19–20: 3rd Annual Life Sciences Forum on Social Media Regulations and Compliance
Alexandria, VA


Augusts 14–16: 6th Annual Forum on Sunshine and Aggregate Spend
Washington, DC

Advertisement
Meeting Global Patient Demand for Access to Medicines Prior to Approval and Launch
On-Demand Webcast
http://pharmexec.com/demand

 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook



Survey
What is your view on the FDA guidance on TV advertising?

Click To Vote
 
Quick Links

GSK Rebuffed by HGS. For the Moment...

China: New Opportunities for Growth

Medical Meetings: Docs Speak Out


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |
 
Visit Pharmaceutical Executive